EUVIMEDEUVIMED entdecken
Crossref

Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum

Lisa A Carmody, Lindsay J Caverly, Linda M Kalikin, Christina S Thornton, Richard H Simon, Donald R VanDevanter, John J LiPuma

Journal of Cystic Fibrosis · 2025

DOI: 10.1016/j.jcf.2024.11.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Lisa A Carmody und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Sputum, Cystic Fibrosis, Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NHLBI NIH HHS, Cystic Fibrosis Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment-associated differences in Pseudomonas aeruginosa (Pa) density in sputum have been used as a response biomarker in clinical trials of cystic fibrosis (CF) therapies. Although most studies have included placebo-treated groups as comparators, variability of Pa density in untreated individuals has rarely been reported. We measured day-to-day differences in Pa density in 267 sputum sample pairs collected from 13 adults with CF during days in which no changes in antibiotic therapy occurred. Although the mean sputum Pa density change across all sample pairs was modest (-0.09 log10 16S rRNA gene copies/mL), variability in day-to-day changes were substantial (SD = 1.09) with one-quarter of sample pairs having >1 log10 differences in Pa density; approximately 8 % of pairs had >2 log10 differences in density. Day-to-day variability in Pa density differed substantially between study participants (p = .001). These results will support the design and interpretation of studies using sputum Pa density change as an efficacy biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SputumCystic FibrosisPseudomonas aeruginosaPseudomonas InfectionsHumansMaleAdultFemaleAnti-Bacterial Agents

Stichwörter der Autor:innen

Bacterial density in sputumPseudomonas airway infectionResponse biomarker

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, United States.
  • Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, United States. Electronic address: jlipuma@umich.edu.

Förderung

  • NHLBI NIH HHS
  • Cystic Fibrosis Foundation
  • National Institutes of Health
  • National Heart Lung and Blood Institute

Zitieren

APA

Carmody, L. A., Caverly, L. J., Kalikin, L. M., Thornton, C. S., Simon, R. H., VanDevanter, D. R., & LiPuma, J. J. (2025). Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2024.11.013

Vancouver

Carmody LA, Caverly LJ, Kalikin LM, Thornton CS, Simon RH, VanDevanter DR, et al. Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2024.11.013

BibTeX
@article{Carmody2025,
  author = {Carmody, Lisa A and Caverly, Lindsay J and Kalikin, Linda M and Thornton, Christina S and Simon, Richard H and VanDevanter, Donald R and LiPuma, John J},
  title = {Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  doi = {10.1016/j.jcf.2024.11.013}
}
Kostenlos starten →